Organization: Health Canada
Year: 2023
Month: January
Request Number: A-2022-000995
Request Summary: The initial cover letters indicating the sponsors for all of the Abbreviated New Drug Submission (ANDS), the brand name of the reference drug production each ANDS and the dosage form of the generic drugs in Health Canada’s list of “Generic Drug Submissions Under Review” dated 2022-10-20 for the medicinal ingredient sugammadex sodium. The Screening Acceptance Letter from Health Canada to all the generic drug manufacturers confirming completion of screening of the ANDS for sugammadex sodium which appears in Health Canada’s list of “Generic Drug Submissions Under Review” dated 2022-10-20.
Disposition: Disclosed in part
Number of pages: 18